From July 31 to August 3, the 38th national pharmaceutical industry information conference in 2021 was grandly held in Jinan. After winning the honor list of "the most growing enterprise in China's pharmaceutical industry" in 2019 and 2020, wanbond Pharmaceutical Group was once again listed in the list of "the most growing enterprise in China's pharmaceutical industry in 2021" by relying on its strong enterprise strength and remarkable brand reputation.

From July 21 to 25, the 2021 mith Conference (full name: China Pharmaceutical and health industry symbiosis Conference) was grandly held in Kunming, and Wanbang xinnuokan, the core product of wanbond Pharmaceutical Group, was held ® After the Ginkgo biloba dropping pill was listed in the "Chinese medicine · brand list" in 2020, it was once again listed as the only Ginkgo biloba preparation variety in the list and the hospital terminal in the "Chinese medicine · brand list" in 2021. This is not only a comprehensive symbol of enterprise strength and influence, but also a prominent manifestation of product competitiveness and brand strength.